ELIQUENT Welcomes Shelley Gandhi to Enhance Pharmacovigilance
ELIQUENT Life Sciences, a known regulatory consulting firm dedicated to innovation in healthcare, is thrilled to announce the addition of Shelley Gandhi, a highly respected expert in pharmacovigilance (PV). This move strengthens ELIQUENT's commitment to providing integrated compliance solutions and enhances their capability to manage risks while accelerating product market entry.
Bringing Global Expertise to ELIQUENT
With over thirty years of experience in PV and risk management, Shelley Gandhi is set to make a significant impact at ELIQUENT. Her extensive tenure with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has equipped her with a deep understanding of European regulatory processes related to ensuring the safety of medicinal products. Gandhi's time at the MHRA, where she held several senior roles, allowed her to gain vital insights into regulatory expectations which are essential for effective risk management.
Impactful Contributions at the European Medicines Agency
During her illustrious career, Shelley served as the UK representative on the EudraVigilance Expert Working Group, directly shaping the European Medicines Agency’s system for managing reports of suspected adverse medicine reactions. Her role was crucial in refining key pharmacovigilance processes throughout Europe, proving her expertise invaluable.
Expanding Pharmacovigilance Solutions
Before joining ELIQUENT, Gandhi dedicated more than a decade to providing strategic PV advice and support to biotechnology firms. Her vast knowledge spans various therapeutic areas, from initial clinical development phases to launch preparations, making her exceptionally qualified to address the unique needs of clients.
A Proactive Approach to Drug Safety and Compliance
At ELIQUENT, Shelley collaborates with clients to ensure adherence to global safety regulations and anticipates necessary adjustments to compliance protocols. Her extensive background in risk management amplifies the firm's capabilities to provide comprehensive PV and Risk Management Solutions in an evolving global landscape.
Comprehensive Pharmacovigilance & Risk Management Services
ELIQUENT’s expanded PV solutions are designed to provide efficient practices that guarantee compliance across different markets. The firm combines decades of experience from its leadership in both public and private sectors to support clients in navigating challenges associated with post-marketing surveillance and adverse event reporting.
Within this evolving regulatory environment, ELIQUENT’s tailored Pharmacovigilance and Risk Management Solutions include:
- Global Support: Expert guidance in navigating global PV regulations.
- Adverse Event Reporting: Comprehensive strategies for identifying and responding to adverse events.
- Regulatory Reporting: Proficient handling of complex regulatory reporting demands.
- Signal Detection: Advanced processes for reporting and communicating risk effectively.
- Risk Assessment & Management: Early identification and planning to manage potential risks.
- Post-Marketing Surveillance: A network of experts to ensure product safety and reporting functions.
- Risk Communications: Development of communication plans to handle safety concerns.
- Clinical Trials Safety Oversight: Resources dedicated to monitoring safety pre- and post-approval.
- Qualified Person for Pharmacovigilance (QPPV): Ensuring client compliance with pharmacovigilance regulations.
- Global PV Training: Customized training programs to maintain outstanding regulatory standards.
Integrated Service Platform at ELIQUENT
ELIQUENT offers a redefined regulatory consulting experience, ensuring comprehensive support across the product lifecycle. The firm’s platform comprises a collaboration of regulatory leaders, industry experts, and technical specialists, streamlining the process of bringing new therapies to market.
Key integrated service offerings at ELIQUENT include:
- Regulatory Affairs Solutions: Navigating clients from innovation through approvals and beyond.
- Pharmacovigilance & Risk Management Solutions: Empowering operations with confidence.
- Quality & Compliance Solutions: Tailored compliance strategies tailored to client needs.
- Remediation Solutions: Expert guidance to navigate remediation challenges.
- Talent Solutions: Scalable teams equipped with the right expertise.
About ELIQUENT Life Sciences
ELIQUENT Life Sciences is a collective of six esteemed regulatory consulting firms, including Validant and Greenleaf Health, uniting to provide unparalleled solutions for pharmaceutical and biotech companies. Their extensive service portfolio enables innovators to navigate complex regulatory paths across various therapeutic areas. With continued backing from leading investors, ELIQUENT remains dedicated to facilitating compliance and authorization for a diverse range of healthcare products.
Frequently Asked Questions
What is ELIQUENT Life Sciences known for?
ELIQUENT Life Sciences specializes in regulatory consulting, offering extensive support in pharmacovigilance and risk management for the healthcare industry.
Who is Shelley Gandhi?
Shelley Gandhi is a renowned expert in pharmacovigilance with over 30 years of experience, recently joining ELIQUENT to enhance its service offerings.
What are the main services provided by ELIQUENT?
ELIQUENT provides services including regulatory affairs, pharmacovigilance, risk management, quality and compliance, and talent solutions.
How does ELIQUENT support clients in compliance?
ELIQUENT offers global support and strategic advice to ensure clients adhere to safety standards and regulatory requirements effectively.
Why is pharmacovigilance important in healthcare?
Pharmacovigilance is crucial for monitoring the safety of medicinal products, preventing adverse reactions, and ensuring patient safety during and after drug approval.
